Moderna is one of the leaders in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency. Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
ModernVivo
ModernVivo develops automated literature review software specifically designed for in vivo researchers. Our platform streamlines the process of searching for and reviewing in-vivo studies, reducing manual workloads that hinder study progress and drives up costs. With ModernVivo’s software, researchers and IACUC committees across pharmaceutical companies, contract research organizations, and academic labs can accelerate timelines, lower operational expenses, and improve translational success.
Moderna
At Moderna, we are delivering on the promise of mRNA science to create a new generation of transformative medicines for patients. We are relentlessly working to grow our cancer therapeutic modality by discovering mRNA medicines that harness the body’s immune system to identify and kill cancer cells in the same way the immune system identifies and targets infections. One example of a promising oncology candidate is the creation of individualized, mRNA-based cancer therapies. We also continue to strengthen our portfolio through strategic collaborations that increase our potential to improve treatment options for patients with cancer. | At Moderna, we are grounded in the belief that mRNA is transformational. And, for us, our covid and RSV vaccines are just the beginning. Our mRNA platform, with its speed, scale, and flexibility, is uniquely suited to tackle current and emerging pathogens that threaten global health. | Moderna is a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines.
Minerva Imaging
Minerva Imaging is an integrated CRO and CDMO specialized in targeted radionuclide therapies and molecular imaging. The company focusses on the use of advanced models within oncology, cardiovascular diseases and in vivo molecular imaging for translational research and drug development. Minerva Imaging engages with its clients to understand their scientific questions and discuss how its methods and capabilities can provide answers. The facility located in Denmark offers best–in–industry fully integrated radiopharmaceutical research, drug development and manufacturing services.
Mindpeak Gmbh
Mulitplex Immunofluorescence Image Analysis Workflow. Building artificial intelligence for pathology. We create artificial intelligence to bring precision and speed to clinical pathology and to get more information out of tissue.
Merck
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on Twitter, Facebook, Instagram, YouTube and LinkedIn. | Verona Pharma is a subsidiary of Merck& Co, Inc.,(Rahway, New Jersey, USA). For more information, please visit www.veronapharma.com. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.merck.com and connect with us on X, Facebook, Instagram, YouTube and LinkedIn. | At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. | We aspire to be the premier research-intensive biopharmaceutical company | We aspire to be the premier research-intensive biopharmaceutical company. Our purpose: We use the power of leading-edge science to help save and improve lives around the world For more than 130 years, and since 1911 in Canada, Merck has brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.
MeltPrep
MeltPrep specializes in laboratory equipment for rapid and lossless prototyping of new dosage forms. Our Vacuum Compression Molding (VCM) technology facilitates formulation screening with mg-to-gram-scale sample molding, ensuring homogeneity directly from powders and eliminating air inclusions. Providing solutions for a wide range of applications, including Hot Melt Extrusion (HME), Amorphous Solid Dispersions (ASD), and implant formulation screening, the VCM Platform stands out as a versatile tool for pharmaceutical innovation. In addition to a variety of standard sample sizes, it enables the molding of single prototypes to screen dosage forms with complex geometries using Free-D Molding. Visit our booth to explore our newest innovations: the MeltPrep Slider – quick and easy thermal analysis in minutes, and the MeltPrep Mixer – lossless shear mixing with milligrams.
Meds 2U: Emergency Dental Kits
Meds 2U: Emergency Dental Kit provides emergency dental kits at an affordable price. We monitor your expiration dates, notify you of any drug recalls, replenish expired or used items, customizable to your practice, and take back any expired items in your kit. We make it easier for you so you can focus on your patients and practice
Medicilon
Medicilon offers fully integrated pharmaceutical services for global scientific community, focusing on providing exceptional client-centered experience and advancing your candidates through the drug discovery process.Our integrated services across biology, chemistry and preclinical services are designed to help clients developing their R&D programs from initial idea stage to IND filing phase. | Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. ❖20 Years of Excellence ❖480 IND Approved by FDA, NMPA, EMA, and TGA ❖2000+ Active Clients Worldwide ❖2600+ Scientists & Research Staff ❖85,000+ m2 Lab Space At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China. For enquiries, please visit our website www.medicilon.com or email marketing@medicilon.com.
Medicilon
Medicilon offers fully integrated pharmaceutical services for global scientific community, focusing on providing exceptional client-centered experience and advancing your candidates through the drug discovery process.Our integrated services across biology, chemistry and preclinical services are designed to help clients developing their R&D programs from initial idea stage to IND filing phase. | Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. ❖20 Years of Excellence ❖480 IND Approved by FDA, NMPA, EMA, and TGA ❖2000+ Active Clients Worldwide ❖2600+ Scientists & Research Staff ❖85,000+ m2 Lab Space At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China. For enquiries, please visit our website www.medicilon.com or email marketing@medicilon.com.